IDRSF (Idorsia) ROE % Adjusted to Book Value : 0.00% (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Idorsia ROE % Adjusted to Book Value?

Idorsia's ROE % for the quarter that ended in Sep. 2024 was 0.00%. Idorsia's PB Ratio for the quarter that ended in Sep. 2024 was N/A. Idorsia's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was N/A.

Idorsia ROE % Adjusted to Book Value Historical Data

The historical data trend for Idorsia's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Idorsia ROE % Adjusted to Book Value Chart

Idorsia Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-5.06

-16.55

-5.47

Idorsia Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															Negative Equity	-	Negative Equity	-	-

Competitive Comparison of Idorsia's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Idorsia's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Idorsia's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Idorsia's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Idorsia's ROE % Adjusted to Book Value falls into.

Idorsia ROE % Adjusted to Book Value Calculation

Idorsia's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Idorsia's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Idorsia ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Idorsia's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Idorsia Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Idorsia Ltd (OTCPK:IDRSF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

IDIAz:UK 0RQE:UK IDIA:Switzerland

Address

Hegenheimermattweg 91, Allschwil, CHE, 4123

Website

https://www.idorsia.com

Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.